Advertisement

The Thorax

  • Michael J. O’Doherty
Part of the Developments in Nuclear Medicine book series (DNUM, volume 31)

Abstract

There are few conditions in humans that affect most people in the population at some time during their lives, lung inflammation/infection is such a problem. Airways inflammation or infection are a major cause of morbidity and accounts for a large number of visits of patients to their primary care physician. The inflammatory reaction is associated with marked vascular change including hyperaemia and vascular leakiness leading to interstitial oedema. These responses to noxious insults to the lung may lead to damage of the epithelium and due to excess production of mucous and cells to deal with the injury, blockage of airways may occur. The type of initiating injury often determines the type of cellular infiltrate and the response of the individual may be excessive leading to other problems in the lung. The response may affect the airflow and therefore delivery of oxygen and perhaps medication. Therapy to the lungs is often appropriately given via the airways by metered dose inhaler or nebulisers, the mode of this delivery can be studied using radionuclides but is beyond the scope of this chapter and has been reviewed recently [1]. The mechanisms behind the clearance of secretions associated with inflammatory and infective diseases are a further area where nuclear medicine techniques have contributed to the understanding of disease processes. Nuclear medicine studies can therefore contribute to the topic of inflammation and infection in the thorax in terms of understanding pathology, disease progression and management as well as investigating methods to improve therapy.

Keywords

Human Immunodeficiency Virus Kawasaki Disease Pneumocystis Carinii Pneumonia Adult Respiratory Distress Syndrome Human Immunodeficiency Virus Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O’Doherty MJ, Miller RF. Aerosols for therapy and diagnosis. Eur J Nucl Med 1993; 20(12), 1201–1213.CrossRefGoogle Scholar
  2. 2.
    O’Doherty MJ, Page CJ, Bradbeer CS et al. Alveolar permeability in HIG patients with pneumocystis carinii pneumonia. Genitourin Med 1987; 63: 268–270.Google Scholar
  3. 3.
    Baron AL, Steinbach LS, Leboit PE, Mills CM, Gee JH, Berger TG. Osteolytic lesions of bacillary angiomatosis in HIV infection: radiologic differentiation from AIDS-related Kaposi sarcoma. Radiology 1990; 177: 77–81.PubMedGoogle Scholar
  4. 4.
    Serry C, Bleck PC, Javid H et al. Sternal wound complications. J Thorax Cardiovasc Surg 1980; 80: 861–867.Google Scholar
  5. 5.
    Salit IE, Detsky AS, Simor AE et al. Gallium-67 scanning in the diagnosis of postoperative sternal osteomyelitis: concise communication. J Nucl Med 1983; 24: 1001–1004.PubMedGoogle Scholar
  6. 6.
    Cooper JA, Elmendorf SL, Teixeira III JP, McCandless BK, Foster ED. Diagnosis of sternal wound infection by technetium-99m-leucocyte imaging. J Nucl Med 1992; 33: 59–65.PubMedGoogle Scholar
  7. 7.
    Cregler LL, Sosa I, Ducey S, Abbey S. Myopericarditis in acquired immunodeficiency syndrome diagnosed by gallium scintigraphy. J Nat Med Assoc. 1990; 82: 511–513.Google Scholar
  8. 8.
    Sty JR, Chusid MJ, Dorrington A, Ga-67 imaging: Kawasaki disease. Clin Nucl Med 1981; 6:112–113.PubMedCrossRefGoogle Scholar
  9. 9.
    Kao CH, Hsieh KS, Wang Yl et al. Comparison of 99mTc HMPAO-labelled white blood cells and 67 Ga citrate scans to detect myocarditis in the acute phase of Kawasaki disease. Nucl Med Commun 1995; 12: 951–958.CrossRefGoogle Scholar
  10. 10.
    Yasuda T. Palcios F, Dec GW et al. Indium-111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987; 76: 306–311.PubMedCrossRefGoogle Scholar
  11. 11.
    Dec GW, Palacios I, Yasuda et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. JACC 1990; 16: 97–104.PubMedGoogle Scholar
  12. 12.
    Frist W. Yasuda T. Segall G et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation 1987; 76: V81–V85.PubMedGoogle Scholar
  13. 13.
    Ballester-Rodes M, Carrio-Gasset I, Abadal-Berini L et al. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin. Am J Cardiol 1988; 62: 623–627.PubMedCrossRefGoogle Scholar
  14. 14.
    Carrio I, Berna L, Ballester M et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1893–1900.PubMedGoogle Scholar
  15. 15.
    Obrador D, Ballester M. Carrio I et al. Active myocardial damage with out attending inflammatory response in dilated cardiomyopathy. J Am Coll Cardiol 1993; 14:1667–1671.CrossRefGoogle Scholar
  16. 16.
    Khaw BA, Klibanov A, O’Donnel SM et al. Gamma imaging with negatively charge modified monoclonal antibody: modification with synthetic polymers. J Nucl Med 1991; 32: 1742–1751.PubMedGoogle Scholar
  17. 17.
    Wiseman J, Rouleau J, Rigo P. Strauss HW, Pitt B. Gallium-67 myocardial imaging for the detection of bacterial endocarditis. Radiology 1976; 120: 135–138.PubMedGoogle Scholar
  18. 18.
    Melvin ET, Berger M, Lutzker LG et al. Noninvasive methods for detection of valve vegetations in infective endocarditis. Am J Cardiol 1981: 47; 271–278.PubMedCrossRefGoogle Scholar
  19. 19.
    Morguet AJ, Munz DL, Ivancevic V et al. Immunoscintigraphy using technetium-99m-labelled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Cardiol 1994; 23: 1171–1178.CrossRefGoogle Scholar
  20. 20.
    Bourke SJ, Banham SW, McKillop JH, Boyd G. Clearance of 99mTc-DTPA in pigeon fancier’s hypersensitivity pneumonitis. Am Rev Respir Dis 1990; 142: 1168–1171.PubMedGoogle Scholar
  21. 21.
    Rinderknecht J, Shapiro L, Krauthammer M et al. Accelerated clearance of small solvents from the lungs in interstitial lung disease. Am Rev Respir Dis 1980; 121: 105–117.PubMedGoogle Scholar
  22. 22.
    Susskind H, Weber DA, Volkow ND et al. Increased lung permeability following longterm use of free-base cocaine (crack) Chest 1991; 100: 903–909.PubMedCrossRefGoogle Scholar
  23. 23.
    Labrune S. Chinet Th, Collignon L, Barritault L, Huchon GJ. Mechanisms of increased epithelial clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J 1994; 7: 651–656.PubMedCrossRefGoogle Scholar
  24. 24.
    Wells AU, Hansell DM, Harrison NK et al. Clearance of inhaled 99mTc DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993; 6: 797–802.PubMedGoogle Scholar
  25. 25.
    Uh S, Lee SM, Kim HT, Chung Y, Kim YH, Park CS. The clearance rate of alveolar epithelium using 99mTc-DTPA in patients with diffuse infiltrating lung disease. Chest 1994; 106: 161–165.PubMedCrossRefGoogle Scholar
  26. 26.
    Line BR, Fulmer JD, Reynolds HY et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation with physiologic and morphologic faetures and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118: 355–365.PubMedGoogle Scholar
  27. 27.
    Line BR, Hunninghake GW, Keogh BA et al. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage. Am Rev Respir Dis 1981; 123: 440–446.PubMedGoogle Scholar
  28. 28.
    Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunnignhake GW. Interstitial lung disease: Current concepts of pathogenasis, staging and therapy. Am J Med 1981; 70: 542–568.PubMedCrossRefGoogle Scholar
  29. 29.
    Richman SD, Levenson SM, Bunn PA, Flinn GS, Johnston GS, De Vita VT. Gallium-67 accumulation in pulmonary lesions associated with bleomycin toxicity. Cancer 1975; 36: 1966–1972.PubMedCrossRefGoogle Scholar
  30. 30.
    MacMahon H and Bekerman C. Diagnostic significance of gallium uptake in patients with normal chest radiographs. Radiology 1978; 127: 189–193.PubMedGoogle Scholar
  31. 31.
    Siemsen JK, Sargent EN, Grebe SF, Winsor Dw, Jacobsen G. Pulmonary concentration of Ga67 in pneumoconiosis. Am J Roentgenol 1974; 120: 815–820.Google Scholar
  32. 32.
    Bekerman C, Hoffner PB, Bitran JD, Gupta RG. Gallium-67 citrate imaging studies of the lung. Semin Nucl Med 1980; 10: 286–301.PubMedCrossRefGoogle Scholar
  33. 33.
    Mason GR, Effros RM, Uszler JM et al. Small solute clearance from the lungs of patients with cardiogenic and noncardiogenic pulmonary edema. Chest 1985; 88: 327–334.PubMedCrossRefGoogle Scholar
  34. 34.
    Terra-Filho M. Vargas FS, Meneguetti JC et al. Pulmonary clearance of technetium 99m diethylene triamine penta acetic acid aerosol in patients with amiodarone pneumonitis. Eur J Nucl Med 1990; 17: 334–337.PubMedCrossRefGoogle Scholar
  35. 35.
    O’Doherty MJ, Van de Pette JEW, Page CJ, Bateman NT, Singh AK, Croft DN. Pulmonary permeability in haematological malignancies: Effects of the disease and cytotoxic agents. Cancer 1986; 58: 1286–1288.CrossRefGoogle Scholar
  36. 36.
    Chopra SK, Taplin GV, Tashkin DP, Elam D. Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis. Thorax 1979; 34: 63–67.PubMedCrossRefGoogle Scholar
  37. 37.
    Niden AH and Mishkin FS. Clinical usefulness of gallium lung scans. Compr Ther 1979; 5: 24–34.PubMedGoogle Scholar
  38. 38.
    Basran GS, Byrne AJ, Hardy JG. A noninvasive technique for monitoring lung vascular permeability in man. Nucl Med Commun 1985; 3: 3–10.CrossRefGoogle Scholar
  39. 39.
    Braude S, Apperley J, Krausz T, Goldman JM, Royston D. Adult respiratory distress syndrome after allogeneic bone marrow transplantation: Evidence for a neutrophil independent mechanism. Lancet 1985; 1: 1239–1242.PubMedCrossRefGoogle Scholar
  40. 40.
    Kaplan JD, Calandrino FS, Schuster DP. A positron emission tomographic comparison of pulmonary vascular permeability during the adult respiratory distress syndrome and pneumonia. Am Rev Respir Dis 1991; 143: 150–154.PubMedGoogle Scholar
  41. 41.
    Velazquez M, Weibel ER, Kuhn C et al. PET evaluation of pulmonary vascular permeability: a structure-function-correlation. J Appl Physiol 1991; 70: 2206–2216.PubMedGoogle Scholar
  42. 42.
    Mintun MA, Dennis DR, Welch MJ, Mathias CJ, Schuster DP. Measurements of pulmonary vascular permeability with PET and gallium-68-transferrin. J Nucl Med 1987; 28: 1704–1716.PubMedGoogle Scholar
  43. 43.
    Mintum MA, Warfel TE, Schuster DP. Evaluating pulmonary vascular permeability with radiolabelled proteins: an error analysis. J Appl Physiol 1990; 68: 1696–1706.Google Scholar
  44. 44.
    Jefferies AL, Coates G, O’Brodovich H. Pulmonary epithelial permeability in hyaline membrane disease. N Eng J Med 1984; 131: 1075–1080.CrossRefGoogle Scholar
  45. 45.
    Sulavik SB, Spencer RP, Palestro CJ et al. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993; 103:403–409.PubMedCrossRefGoogle Scholar
  46. 46.
    Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue S, Castriotta RJ. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31:1909–1914.PubMedGoogle Scholar
  47. 47.
    Baughman RP, Fernandez M, Bosken C. Comparison of gallium-67 scanning, bronchoalveolar lavage and serum angiotensin-convering enzymelevels in pulmonary sarcoidosis: predicting response to therapy. Am Rev Respir Dis 1984; 129: 676.PubMedGoogle Scholar
  48. 48.
    Lawrence EC, Teague RB, Gottlieb MS. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am J Med 1983; 74: 747.PubMedCrossRefGoogle Scholar
  49. 49.
    Alberts C, Van der Schoot JB. Standardized quantitative 67Ga scintigraphy in pulmonary sarcoidosis. Sarcoidosis 1988; 5: 111–118.PubMedGoogle Scholar
  50. 50.
    Lewis PJ. Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647–1649.PubMedGoogle Scholar
  51. 51.
    Valind SO, Rhodes CG, Paltin C, Suzuki T, Hughes JMB. Measurements of pulmonary glucose metabolism in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: A53.Google Scholar
  52. 52.
    Brudin LH, Valind SO, Rhodes CG et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21: 297–305.PubMedCrossRefGoogle Scholar
  53. 53.
    Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluoride-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulocytes studied by microautoradiography. J Nucl Med 1992; 33: 1972–1980.PubMedGoogle Scholar
  54. 54.
    Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon GJ. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990; 45: 675–678.PubMedCrossRefGoogle Scholar
  55. 55.
    Dusser DJ, Collignon MA, Stanislas-Leguern G, Barritault LG, Chretien J, Huchon GJ. Respiratory clearance of 99mTc DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis 1986; 134: 493–497.PubMedGoogle Scholar
  56. 56.
    Watanabe N, Inoue T, Oriuchi H, Suzuki H, Hirano T, Endo K. Increased pulmonary clearance in aerosolised 99Tcm-DTPA in patients with a subset of stage I sarcoidosis. Nucl Med Commun 1995; 16: 464–467.PubMedCrossRefGoogle Scholar
  57. 57.
    Vanhagen PM, Krenning EP, Reubi JC et al. Somatostatin analogue scintigraphy in granulomatous disease. Eur J Nucl Med 1994; 21: 497–502.PubMedCrossRefGoogle Scholar
  58. 58.
    Diot R, Lemarie E, Baulie JL et al. Scintigraphy with J001 macrophage targeting glycolipeptide. A new approach for sardoisosis imaging. Chest 1992; 102: 670–676.PubMedCrossRefGoogle Scholar
  59. 59.
    Jonker ND, Peters AM, Gaskin G, Pusey CD, Lavender JP. A retrospective study of radiolabeled granulocyte kinetics in patients with systemic vasculitis. J Nucl Med 1992; 33: 491–497.PubMedGoogle Scholar
  60. 60.
    Wraight EP, Llewellyn MB, Lockwood CM. Indium-111 leucocyte imaging in systemic vasculitis. Nucl Med Commun 1990; 11: 201–202.Google Scholar
  61. 61.
    Thadepalli H, Rambhatla K, Mishkin FS, Khurana M, Niden AH. Correlation of microbiologic findings and 67gallium scans in patients with pulmonary infections. Chest 1977; 72: 442–448.PubMedCrossRefGoogle Scholar
  62. 62.
    Patz EF, Lowe VJ, Hoffman JM et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487–490.PubMedGoogle Scholar
  63. 63.
    Currie DC, Saverymuttu SH, Peters AM et al. Indium-111 labelled granulocyte accumulation in the respiratory tract of patients with bronchiectasis. Lancet 1987; 1:1335–1339.PubMedCrossRefGoogle Scholar
  64. 64.
    Saverymuttu SH, Phillips G, Peters AM, Lavender JP. Ill-Indium autologous leucocyte scanning in lobar pneumonia and lung abscesses. Thorax 1985; 40:925–930.PubMedCrossRefGoogle Scholar
  65. 65.
    Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, Stover DE. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am Rev Respir Dis 1987; 135:504–509.PubMedGoogle Scholar
  66. 66.
    O’Doherty MJ, Breen D, Page CJ, Barton I, Nunan TO. Lung 99m-Tc DTPA transfer in renal disease and pulmonary infection. Nephrol Dial Transplant 1991; 6: 582–587.Google Scholar
  67. 67.
    Coleman D, Hattner R, Luce J. Dodek P, Golden J, Murray J, Correlation between gallium lung scans and fibreoptic bronchoscopy in patients with suspected pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis 1984; 130: 1166–1169.PubMedGoogle Scholar
  68. 68.
    Kramer EL, Sänger JJ, Garay SM, Grossman R, Tiu S, Banner H. Diagnostic implications of Ga-67 chest scan patterns in human immunodeficiency virus seropositive patients. Radiology 1989; 170: 671–676.PubMedGoogle Scholar
  69. 69.
    Hecht D, Snydman D, Crumpacker C, Werner B, Heinz-Lacey B. Gancyclovir for treatment of renal transplant associated primary cytomegalovirus pneumonia. J Infect Dis 1988; 157: 186–189.CrossRefGoogle Scholar
  70. 70.
    O’Doherty MJ, Revell P, Page CJ, Lee S, Mountford PJ, Numan TO. Donor leucocyte imaging in patients with AIDS. A preliminary communication. Eur J Nucl Med 1990; 17: 327–333.CrossRefGoogle Scholar
  71. 71.
    Fineman DS, Palestro CJ, Kim CK et al. Detection of abnormalities in febrile AIDS patients with In-111-labelled leucocyte and Ga-67 scintigraphy. Radiology 1989; 170: 677–680.PubMedGoogle Scholar
  72. 72.
    Prvulovich EM, Miller RF, Costa DC et al. Immunoscintigraphy with a 99TcM-labelled antigranulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS. Nucl Med Commun 1995; 16: 838–845.PubMedCrossRefGoogle Scholar
  73. 73.
    Cordes M, Roll D, Langer M, Ruhnke M et al. Diagnostic value of early gallium-67 scans (4 h p.i.) in patients with AIDS and PCP. Eur J Nucl Med 1989; 15: 172.Google Scholar
  74. 74.
    Bitran J, Beckerman C, Weinstein R, Bennet C, Ryo U, Pinsky S. Patterns of gallium-67 scintigraphy in patients with acquired syndrome and the AIDS related complex. J Nucl Med 1987; 28: 1103–1106.PubMedGoogle Scholar
  75. 75.
    Kramer EL, Sänger JJ, Garay SM et al. Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med 1987; 28: 1107–1114.PubMedGoogle Scholar
  76. 76.
    Miller RF. Nuclear medicine and AIDS. Eur J Nucl Med 1990; 16: 103–118.PubMedCrossRefGoogle Scholar
  77. 77.
    Palestro CJ,. The current role of gallium imaging in infection. Seminars in Nucl Med 1994; 24: 128–141.CrossRefGoogle Scholar
  78. 78.
    Tumeh SS, Belville JS, Pugatch R, McNeil B. Ga-67 scintigraphy and computed tomography in the diagnosis of pneumocystis carinii pneumonia in patients with AIDS. A prospective comparison. Clin Nucl Med 1992; 17: 387–394.PubMedCrossRefGoogle Scholar
  79. 79.
    Tuazon CV, Delaney MD, Simon GL et al. Utility of gallium-67 scintigraphy and bronchial washings in the diagnosis and treatment of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1985; 132: 1087–1092.PubMedGoogle Scholar
  80. 80.
    Woolfenden JM, Carrasquillo JA, Larson SM et al. Acquired immunodeficiency syndrome. Ga-67 citrate imaging. Radiology 1987; 162: 383–387.PubMedGoogle Scholar
  81. 81.
    Bradburne RM, Ettensohn DB, Opal SM, McCool FD. Relapse pf pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis. Thorax 1989, 44: 591–593.PubMedCrossRefGoogle Scholar
  82. 82.
    Schiff RG, Kabat L, Kamain N et al. Gallium scanning in lymphoid interstitial pneumonitis in children with AIDS. J Nucl Med 1987; 28: 1915–1919.PubMedGoogle Scholar
  83. 83.
    Ognibene FP, Masur H, Rogers P et al. Nonspecific interstitial pneumonitis without evidence of pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988; 109: 179–183.Google Scholar
  84. 84.
    Fischman JA, Strauss HW, Fischman AJ et al. Imaging of pneumocystis carinii pneumonia with 111In-labelled non-specific polyclonal IgG: an experimental study in rats. Nucl Med Commun 1991; 12: 175–187.PubMedCrossRefGoogle Scholar
  85. 85.
    Rubin RH, Fischman AJ, Gallahan RJ et al. III-In-labelled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med 1989; 321: 935–940.PubMedCrossRefGoogle Scholar
  86. 86.
    Rubin RH, Fischman AJ, Needleman M et al. Radiolabelled, nonspecific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and Technetium-99m-labelled albumin. J Nucl Med 1989; 30: 385–389.PubMedGoogle Scholar
  87. 87.
    Buscombe J, Lui D, Ensing G, De Jong R, Ell PJ. 99mTc human immunoglobulin (HIgG): first results of a new agent for the localisation of infection and inflammation. Eur J Nucl Med 1990; 16: 649–655.PubMedCrossRefGoogle Scholar
  88. 88.
    Buscombe J, Oyen WJG, Grant A et al. Indium-111-labelled polyclonal human immunoglobulin: Identifying focal infection in patients positive for human immunodeficiency virus. J Nucl Med 1993; 34:1621–1625.PubMedGoogle Scholar
  89. 89.
    Goldenberg DM, Sharkey RM, Udem S et al. Immunoscintigraphy of pneumocystis carinii pneumonia in AIDS patients. J Nucl Med 1994; 35: 1028–1034.PubMedGoogle Scholar
  90. 90.
    Rosso J, Guillon JM, Parrot A et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med 1992; 33: 81–87.PubMedGoogle Scholar
  91. 91.
    O’Doherty MJ, Page CJ, Bradbeer CS et al. The place of lung 99mTc-DTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Resp Med 1989; 83: 395–401.CrossRefGoogle Scholar
  92. 92.
    Leach R, Davidson C, O’Doherty MJ, Nayagam M, Tang A, Bateman N. Noninvasive management of fever and breathlessness in HIV positive patients. Eur J Resp Med 1991; 4: 19–25.Google Scholar
  93. 93.
    Van der Wall H, Murray IPC, Jones PD, Mackey DWJ, Walker BM, Monaghan P. Optimising technetium 99m diethylene triamine penta-acetate lung clearance in patients with the acquired immunodeficiency syndrome. Eur J Nucl Med 1991; 18: 235–240.PubMedCrossRefGoogle Scholar
  94. 94.
    Robinson DS, Cunningham DA, Dave S, Fleming J, Mitchell DM. Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in pneumocystis carinii pneumonia in AIDS. Thorax 1991; 46: 722–726.PubMedCrossRefGoogle Scholar
  95. 95.
    O’Doherty MJ. 99mTc DTPA transfer/permeability in patients with HIV disease. J Nucl Med 1995; 39:231–242.Google Scholar
  96. 96.
    Monaghan P, Provan I, Murray C et al. An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 1991; 32:1945–1949.PubMedGoogle Scholar
  97. 97.
    O’Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning in patients with HIV disease. Eur J Nucl Med 1995; 5: 918 (Abstract).Google Scholar
  98. 98.
    Lisbona R, Hakim TS, Dean GW et al. Regional pulmonary perfusion following heart lung transplantation. J Nucl Med 1989; 30:1297–1301.PubMedGoogle Scholar
  99. 99.
    Skeens JL, Fuhrman CR, Yousem SA. Bronchiolitis obliterans in heart-lung transplantation patients. AJR 1989; 153:253–256.PubMedGoogle Scholar
  100. 100.
    Herve PA, Silbert D, Mensch J et al. Increased lung clearance of 99mTc DTPA in allograft lung rejection. The Paris-Sud Lung Transplant Group. Am Rev Respir Dis 1991; 144:1333–1336.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Michael J. O’Doherty

There are no affiliations available

Personalised recommendations